TARSUS PHARMACEUTICALS INC (TARS) Stock Income Statement
NASDAQ:TARS - Nasdaq - US87650L1035 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 233.67M | 182.95M | 17.45M | 25.82M | 57.03M | |||
| Cost Of Goods | 16.38M | 12.83M | 1.59M | 960.00K | 2.08M | |||
| Gross Profit | 217.29M | 170.13M | 15.85M | 24.86M | 54.95M | |||
| Operating Expenses | 326.46M | 290.70M | 159.01M | 87.57M | 67.10M | |||
| Research and Development | 55.73M | 53.39M | 50.31M | 42.62M | 41.71M | |||
| Selling, General, and Administrative Expenses | 270.73M | 237.31M | 108.70M | 44.95M | 25.40M | |||
| Operating Income | -109.17M | -120.57M | -143.16M | -62.71M | -12.16M | |||
| Interest Income/Expense | 6.27M | 6.45M | 7.63M | 530.00K | -1.54M | |||
| Other Income/Expense | -100.00K | 506.00K | -366.00K | 90.00K | -70.00K | |||
| Non Recurring Items | N/A | -1.94M | N/A | N/A | N/A | |||
| Income Before Taxes | -104.94M | -115.55M | -135.89M | -62.10M | -13.77M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 60.00K | |||
| Net Income | -104.94M | -115.55M | -135.89M | -62.09M | -13.83M | |||
| EBITDA | -107.75M | -119.34M | -142.28M | -62.38M | -11.85M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.73 | -3.07 | -4.62 | -2.52 | -0.67 | |||
| Non GAAP EPS | -2.73 | -3.10 | -4.64 | -2.55 | -0.68 | |||
| Statistics | ||||||||
| Gross Profit Margin | 92.99% | 92.99% | 90.87% | 96.28% | 96.35% | |||
| Profit Margin | -44.91% | -63.16% | -778.89% | -240.47% | -24.25% | |||
| Operating Profit Margin | -46.72% | -65.90% | -820.53% | -242.87% | -21.32% | |||
All data in USD